Daily Sabah logo

Politics
Diplomacy Legislation War On Terror EU Affairs Elections News Analysis
TÜRKİYE
Istanbul Education Investigations Minorities Expat Corner Diaspora
World
Mid-East Europe Americas Asia Pacific Africa Syrian Crisis Islamophobia
Business
Automotive Economy Energy Finance Tourism Tech Defense Transportation News Analysis
Lifestyle
Health Environment Travel Food Fashion Science Religion History Feature Expat Corner
Arts
Cinema Music Events Portrait Reviews Performing Arts
Sports
Football Basketball Motorsports Tennis
Opinion
Columns Op-Ed Reader's Corner Editorial
PHOTO GALLERY
JOBS ABOUT US RSS PRIVACY CONTACT US
© Turkuvaz Haberleşme ve Yayıncılık 2026

Daily Sabah - Latest & Breaking News from Turkey | Istanbul

  • Politics
    • Diplomacy
    • Legislation
    • War On Terror
    • EU Affairs
    • Elections
    • News Analysis
  • TÜRKİYE
    • Istanbul
    • Education
    • Investigations
    • Minorities
    • Expat Corner
    • Diaspora
  • World
    • Mid-East
    • Europe
    • Americas
    • Asia Pacific
    • Africa
    • Syrian Crisis
    • Islamophobia
  • Business
    • Automotive
    • Economy
    • Energy
    • Finance
    • Tourism
    • Tech
    • Defense
    • Transportation
    • News Analysis
  • Lifestyle
    • Health
    • Environment
    • Travel
    • Food
    • Fashion
    • Science
    • Religion
    • History
    • Feature
    • Expat Corner
  • Arts
    • Cinema
    • Music
    • Events
    • Portrait
    • Reviews
    • Performing Arts
  • Sports
    • Football
    • Basketball
    • Motorsports
    • Tennis
  • Gallery
  • Opinion
    • Columns
    • Op-Ed
    • Reader's Corner
    • Editorial
  • TV
showıng 16 results

Sort by

  • Newest first
  • Oldest first

Date range

  • Any Time
  • Past 24 Hours
  • Past 7 Days
  • Past 30 Days

Section

  • all sections
  • Politics
  • Turkey
  • World
  • Business
  • Sports
  • Life
  • Arts
  • Opinion
  • The German share price index DAX graph is pictured at the stock exchange, Frankfurt, Germany, Jan. 20, 2026. (Reuters Photo)

    Global shares dip as Anthropic update hits software stocks

    Feb 04, 2026
  • The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices, Bagsvaerd, Copenhagen, Denmark, Dec. 3, 2025. (Reuters Photo)

    Sales, profits warning hammers Novo Nordisk's stock

    Feb 04, 2026
  • When people stop taking the new generation of weight-loss drugs, they pile back on the kilos four times faster than they would after ending diet and exercise regimes, new research found Thursday. (Shutterstock Photo)

    Weight rapidly returns after stopping popular obesity drugs: Study

    Jan 08, 2026
  • Traders work on the floor of the New York Stock Exchange (NYSE) at the opening bell in New York, U.S., Sept. 15, 2025. (AFP Photo)

    Wall Street rolls to more records on Intel's best day since 1980s

    Sep 19, 2025
  • The logo of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, is seen outside its building, Bagsvaerd, Denmark, Feb. 5, 2025. (AFP Photo)

    Ozempic-maker Novo Nordisk to cut 9,000 jobs amid rising competition

    Sep 10, 2025
  • A signage of Novo Nordisk is seen during the China International Supply Chain Expo (CISCE), Beijing, China, July 17, 2025. (AFP Photo)

    Novo Nordisk picks new CEO, sees shares slump as it cuts guidance

    Jul 29, 2025
  • The logo of Danish drugmaker Novo Nordisk in their offices, Hillerod, Denmark, Sept. 26, 2023. (Reuters Photo)

    Big Pharma on edge as US-EU tariff spat poses risk for drug sales

    Mar 18, 2025
  • Trucks wait in line to cross into the United States near the border customs control at the World Trade Bridge, Nuevo Laredo, Mexico, Nov. 26, 2024. (Reuters Photo)

    Tech, cars, medicines: Who would pay for all Trump's tariffs?

    Feb 23, 2025
  • A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, near Copenhagen, Denmark, March 8, 2024. (Reuters Photo)

    Novo Nordisk invests $1.2B to build new factory in Denmark

    Dec 16, 2024
  • An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed, New York City, U.S., Dec. 11, 2023. (Reuters Photo)

    UK to trial use of weight-loss jabs to boost job prospects, health

    Oct 15, 2024
Prev 1 2 Next
results per page
10 50
  • POLITICS
  • Diplomacy
  • Legislation
  • War On Terror
  • EU Affairs
  • News Analysis
  • TÜRKİYE
  • Istanbul
  • Education
  • Investigations
  • Minorities
  • Diaspora
  • World
  • Mid-East
  • Europe
  • Americas
  • Asia Pacific
  • Africa
  • Syrian Crisis
  • İslamophobia
  • Business
  • Automotive
  • Economy
  • Energy
  • Finance
  • Tourism
  • Tech
  • Defense
  • Transportation
  • News Analysis
  • Lifestyle
  • Health
  • Environment
  • Travel
  • Food
  • Fashion
  • Science
  • Religion
  • History
  • Feature
  • Expat Corner
  • Arts
  • Cinema
  • Music
  • Events
  • Portrait
  • Performing Arts
  • Reviews
  • Sports
  • Football
  • Basketball
  • Motorsports
  • Tennis
  • Opinion
  • Columns
  • Op-Ed
  • Reader's Corner
  • Editorial
  • Photo gallery
  • DS TV
  • Jobs
  • privacy
  • about us
  • contact us
  • RSS
© Turkuvaz Haberleşme ve Yayıncılık 2021